| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18821658 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 108 journal articles in the PubMed database | Email to a friend | | |
| Bejarano V, Quinn M, Conaghan PG, et al.
Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis. [Journal Article, Research Support, Non-U.S. Gov't]
Arthritis Rheum 2008 Oct 15; 59(10):1467-74.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Keystone EC, Kavanaugh AF, Sharp JT, et al.
Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Arthritis Rheum 2004 May; 50(5):1400-11.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Breedveld FC, Weisman MH, Kavanaugh AF, et al.
The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. [Journal Article, Multicenter Study, Randomized Controlled Trial]
Arthritis Rheum 2006 Jan; 54(1):26-37.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Weisman MH, Moreland LW, Furst DE, et al.
Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study. [Clinical Trial, Clinical Trial, Phase I, Journal Article, Multicenter Study, Randomized Controlled Trial]
Clin Ther 2003 Jun; 25(6):1700-21.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Weinblatt ME, Keystone EC, Furst DE, et al.
Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Arthritis Rheum 2003 Jan; 48(1):35-45.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Kimel M, Cifaldi M, Chen N, et al.
Adalimumab plus Methotrexate Improved SF-36 Scores and Reduced the Effect of Rheumatoid Arthritis (RA) on Work Activity for Patients with Early RA. [JOURNAL ARTICLE]
J Rheumatol 2007 Dec 15.
Abstract | Full Citation | Find Related Articles | | Chen YF, Jobanputra P, Barton P, et al.
A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness. [Journal Article]
Health Technol Assess 2006 Nov; 10(42):1-248.
Abstract | Full Citation | Find Related Articles | | Furst DE, Schiff MH, Fleischmann RM, et al.
Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis). [Clinical Trial, Journal Article, Randomized Controlled Trial]
J Rheumatol 2003 Dec; 30(12):2563-71.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Maini RN, Breedveld FC, Kalden JR, et al.
Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Arthritis Rheum 2004 Apr; 50(4):1051-65.
Abstract | Full Citation | Find Related Articles |   |
|
| |
Advertise on this site.
|
